Vincent K. Lam

5.1k total citations
72 papers, 1.8k citations indexed

About

Vincent K. Lam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Vincent K. Lam has authored 72 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Vincent K. Lam's work include Lung Cancer Treatments and Mutations (26 papers), Cancer Genomics and Diagnostics (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Vincent K. Lam is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Cancer Genomics and Diagnostics (17 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Vincent K. Lam collaborates with scholars based in United States, Hong Kong and China. Vincent K. Lam's co-authors include Juliana C.N. Chan, Ronald C.W., Wing‐Yee So, Jean Woo, E. M. C. Lau, Athena W. L. Hong, Maggie Ng, John V. Heymach, Maggie C. Y. Ng and Bermseok Oh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Vincent K. Lam

65 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent K. Lam United States 21 538 537 432 375 313 72 1.8k
Naoko Honma Japan 26 520 1.0× 603 1.1× 342 0.8× 489 1.3× 461 1.5× 88 2.0k
Antien L. Mooyaart Netherlands 17 450 0.8× 350 0.7× 255 0.6× 150 0.4× 161 0.5× 59 2.2k
Elizabeth L. Barry United States 28 487 0.9× 564 1.1× 418 1.0× 187 0.5× 223 0.7× 79 2.2k
Xu Guan China 22 549 1.0× 480 0.9× 306 0.7× 121 0.3× 273 0.9× 101 1.7k
Michael E. Grossmann United States 23 686 1.3× 614 1.1× 170 0.4× 292 0.8× 318 1.0× 34 1.7k
Cristian Loretelli Italy 20 570 1.1× 382 0.7× 196 0.5× 117 0.3× 413 1.3× 65 1.4k
Xiaohong R. Yang United States 28 788 1.5× 1.2k 2.2× 555 1.3× 483 1.3× 866 2.8× 106 2.7k
Emma H. Allott United States 22 526 1.0× 651 1.2× 771 1.8× 160 0.4× 1.0k 3.3× 69 2.1k
Megan S. Rice United States 22 171 0.3× 411 0.8× 375 0.9× 159 0.4× 170 0.5× 92 1.8k
Axel Muendlein Austria 24 615 1.1× 192 0.4× 143 0.3× 227 0.6× 251 0.8× 124 1.7k

Countries citing papers authored by Vincent K. Lam

Since Specialization
Citations

This map shows the geographic impact of Vincent K. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent K. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent K. Lam more than expected).

Fields of papers citing papers by Vincent K. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent K. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent K. Lam. The network helps show where Vincent K. Lam may publish in the future.

Co-authorship network of co-authors of Vincent K. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent K. Lam. A scholar is included among the top collaborators of Vincent K. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent K. Lam. Vincent K. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Lanlan, Luping Cong, Ming Zhao, et al.. (2025). The Therapeutic Potential of EGCG and Pro-EGCG in Mitigating Ovarian Hyperstimulation Syndrome: Unraveling the Modulatory Mechanism through the VEGF Pathway. International Journal of Biological Sciences. 21(7). 3045–3060.
2.
Sun, Lova, Joshua E. Reuss, Geoffrey Liu, et al.. (2023). P2.31-05 Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data. Journal of Thoracic Oncology. 18(11). S408–S409.
3.
Tran, Hai T., Simon Heeke, Sheeba J. Sujit, et al.. (2023). Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Annals of Oncology. 35(2). 183–189. 32 indexed citations
4.
Liang, Kaili, Josephine Feliciano, Joseph C. Murray, et al.. (2023). Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis. ESMO Open. 9(1). 102199–102199. 1 indexed citations
5.
Prichett, Laura, Julie R. Brahmer, Patrick M. Forde, et al.. (2021). Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy. Lung Cancer. 154. 36–43. 38 indexed citations
6.
Gilot, David, Seong Beom Ahn, Vincent K. Lam, et al.. (2021). Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers. 13(20). 5180–5180. 17 indexed citations
7.
Lewis, Whitney E., Lingzhi Hong, Frank E. Mott, et al.. (2021). Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations. JTO Clinical and Research Reports. 2(11). 100237–100237. 22 indexed citations
8.
Lam, Vincent K., et al.. (2020). Can subcentimetre ultrasound detected angiomyolipomas be safely disregarded?. Clinical Radiology. 75(4). 287–292. 4 indexed citations
9.
Elamin, Yasir Y., Jacqulyne Robichaux, Mehmet Altan, et al.. (2019). MA09.03 Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(10). S282–S283. 13 indexed citations
10.
Tran, Hai T., Vincent K. Lam, Lingzhi Hong, et al.. (2019). P1.01-98 Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing. Journal of Thoracic Oncology. 14(10). S399–S400. 1 indexed citations
11.
Negrão, Marcelo V., Vincent K. Lam, Alexandre Reuben, et al.. (2019). PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(6). 1021–1031. 69 indexed citations
12.
Cascone, Tina, William N. William, Annikka Weissferdt, et al.. (2018). Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC). Annals of Oncology. 29. viii738–viii738. 6 indexed citations
13.
Lam, Vincent K., David S. Hong, John V. Heymach, et al.. (2018). Safety and anti-tumor effects of MAGE-A10c796 TCR T-cells in two clinical trials. Annals of Oncology. 29. viii731–viii731. 2 indexed citations
14.
Lam, Vincent K., Søren M. Bentzen, Pranshu Mohindra, et al.. (2016). Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC). Lung Cancer. 104. 52–57. 64 indexed citations
15.
Wang, Ying, Andrea O. Y. Luk, Maggie C. Y. Ng, et al.. (2013). Additive effect of aldose reductase Z-4 microsatellite polymorphism and glycaemic control on cataract development in type 2 diabetes. Journal of Diabetes and its Complications. 28(2). 147–151. 7 indexed citations
16.
17.
Digby, Janet E., Eileen McNeill, Oliver J. Dyar, et al.. (2009). Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis. 209(1). 89–95. 95 indexed citations
18.
Koevary, Steven B., et al.. (2003). Accumulation of Porcine Insulin in the Rat Brain and Cerebrospinal Fluid Following Ocular Application. Journal of Ocular Pharmacology and Therapeutics. 19(4). 377–384. 18 indexed citations
19.
Lau, E. M. C., Vincent K. Lam, M. Li, Kevin Ki‐Wai Ho, & Jean Woo. (2002). Vitamin D Receptor Start Codon Polymorphism (Fok I) and Bone Mineral Density in Chinese Men and Women. Osteoporosis International. 13(3). 218–221. 19 indexed citations
20.
Fiuczynski, Marc E., Vincent K. Lam, & Brian N. Bershad. (1998). The design and implementation of an IPv6/IPv4 network address and protocol translator. USENIX Annual Technical Conference. 71(713). 17–17. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoko Honma Breakdown of academic impact, for papers by Antien L. Mooyaart Breakdown of academic impact, for papers by Elizabeth L. Barry Breakdown of academic impact, for papers by Xu Guan Breakdown of academic impact, for papers by Michael E. Grossmann Breakdown of academic impact, for papers by Cristian Loretelli Breakdown of academic impact, for papers by Xiaohong R. Yang Breakdown of academic impact, for papers by Emma H. Allott Breakdown of academic impact, for papers by Megan S. Rice Breakdown of academic impact, for papers by Axel Muendlein
Rankless by CCL
2026